Canaccord Genuity Group lowered shares of Olaplex (NASDAQ:OLPX – Free Report) from a strong-buy rating to a hold rating in a report issued on Thursday,Zacks.com reports.
Other equities analysts have also issued research reports about the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Olaplex in a research note on Thursday, January 22nd. Telsey Advisory Group upped their target price on Olaplex from $2.00 to $2.06 and gave the stock a “market perform” rating in a research note on Friday. Northland Securities lowered Olaplex from a “strong-buy” rating to a “hold” rating in a report on Thursday. Evercore set a $2.50 price target on Olaplex in a research report on Friday, March 6th. Finally, Zacks Research raised Olaplex from a “strong sell” rating to a “hold” rating in a report on Thursday, February 19th. One equities research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Olaplex has an average rating of “Hold” and an average price target of $1.89.
Get Our Latest Report on Olaplex
Olaplex Stock Up 0.5%
Olaplex (NASDAQ:OLPX – Get Free Report) last issued its earnings results on Thursday, March 5th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. The firm had revenue of $105.12 million during the quarter, compared to analysts’ expectations of $104.21 million. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. The firm’s revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.01 earnings per share. As a group, equities research analysts forecast that Olaplex will post 0.1 earnings per share for the current year.
Insiders Place Their Bets
In other news, insider Trisha L. Fox sold 26,426 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $1.26, for a total transaction of $33,296.76. Following the sale, the insider directly owned 721,169 shares of the company’s stock, valued at $908,672.94. This represents a 3.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Catherine Dunleavy sold 93,809 shares of the firm’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $118,199.34. Following the sale, the chief financial officer owned 3,026,885 shares in the company, valued at $3,813,875.10. This trade represents a 3.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 215,442 shares of company stock worth $271,457. Company insiders own 4.30% of the company’s stock.
Hedge Funds Weigh In On Olaplex
A number of hedge funds have recently bought and sold shares of OLPX. Headlands Technologies LLC acquired a new stake in Olaplex in the fourth quarter valued at approximately $25,000. Chilton Capital Management LLC acquired a new position in shares of Olaplex during the 3rd quarter worth approximately $26,000. Abel Hall LLC purchased a new position in shares of Olaplex during the 4th quarter valued at approximately $27,000. Schonfeld Strategic Advisors LLC purchased a new position in shares of Olaplex during the 3rd quarter valued at approximately $30,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in Olaplex in the 3rd quarter worth $32,000. Hedge funds and other institutional investors own 87.37% of the company’s stock.
Olaplex News Roundup
Here are the key news stories impacting Olaplex this week:
- Positive Sentiment: Henkel agreed to acquire Olaplex for $2.06 per share (≈$1.4 billion), a ~55% premium to the pre-announcement close; the deal is being pitched as enabling greater investment and distribution for the brand. OLAPLEX to be Acquired by Henkel for $1.4 Billion
- Positive Sentiment: Heavy bullish activity and strong market reaction: premarket headlines and commentary noted a large surge after the announcement, and unusual options activity (large buy of calls) signaled speculative and takeover-arbitrage positioning. Wall Street Breakfast Podcast: Henkel Adds Shine With Olaplex
- Neutral Sentiment: Small analyst adjustments: Telsey Advisory Group raised its price target marginally to $2.06 and kept a “market perform” rating — a modest validation of the deal price but not a strong new bullish signal. Benzinga
- Negative Sentiment: Multiple shareholder-law firms have launched investigations into whether Olaplex shareholders received a fair price or whether there were breaches of fiduciary duty in connection with the sale — this raises litigation risk and could complicate closing/timing. M&A Class Action Firm Announces Investigation Ademi Firm Investigates Fair Price
- Negative Sentiment: Critical analysis and a downgrade: commentary pieces flagged negative implications of the sale for certain stakeholders, and Northland downgraded the stock from “strong-buy” to “hold” — both could reduce enthusiasm among some investors. Henkel Buys Olaplex – Implications Are Negative Zacks (Northland downgrade)
Olaplex Company Profile
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
Further Reading
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
